منابع مشابه
Triple Reuptake Inhibitors: A Premise and Promise
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is plausible they may have potential efficacy in obesity, addiction, and pain syndromes. The curren...
متن کاملGlobal Services The premise and promise of sense and respond
Between May 1994 and November 1998, more than 3,000 executives from a variety of industries, government agencies and educational institutions attended strategy courses at the IBM Advanced Business Institute. All were asked a question deeply relevant to the future survival and success of their organizations: What kind of change do you expect your organization to face during the next decade? Fift...
متن کاملPharmacologic vitreolysis--premise and promise of the first decade.
Pharmacologic Vitreolysis— Premise and Promise of the First Decade The term pharmacologic vitreolysis first appeared in the world’s literature one decade ago in the pages of the journal Retina.1 The coining of this term formalized a new field and was predicated on a premise and a promise. The premise was that we now understood enough about the molecular organization, structure, and physiology o...
متن کاملSerotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
The precise mechanisms of pain perception and transmission in the central nervous system have not been fully elucidated. However, extensive data support a role for the monoamine neurotransmitters, serotonin and norepinephrine, in the modulation of pain. Experiments with animal models of pain indicate that noradrenergic interventions, and to a lesser extent serotonergic interventions, reduce pai...
متن کاملInternational Practitioner Data Bank: false premise, false promise.
In 1984, the US General Accounting Office issued a report pointing out that physicians who lost their licence to practice in one state were continuing to practice in another [1]. In 1986, a federal court issued a ruling that physicians carrying out peer review activities in an Oregon medical clinic violated antitrust laws [2]. Both actions triggered calls for congressional action. Consumer advo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Clinical Practice Oncology
سال: 2005
ISSN: 1743-4254,1743-4262
DOI: 10.1038/ncponc0220